Nath Bio-Genes (India) Limited
NSE: NATHBIOGEN BSE: NATHBIOGEN
Prev Close
139.58
Open Price
141.91
Volume
23,510
Today Low / High
141.58 / 150.01
52 WK Low / High
136 / 238.69
Range
142 - 157
Prev Close
140.5
Open Price
142.5
Volume
789
Today Low / High
141.95 / 148.45
52 WK Low / High
136 / 238
Range
141 - 156
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 149.49 (target range: 142 - 157), reflecting a change of 9.91 (7.09987%). On the BSE, it is listed at 148.45 (target range: 141 - 156), showing a change of 7.95 (5.65836%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Nath Bio-Genes (India) Limited Graph
Nath Bio-Genes (India) Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Nath Bio-Genes (India) Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 149.49, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 148.45 | 149.93 | 134.94 - 164.93 |
| 151.42 | 121.14 - 181.70 | ||
| 152.90 | 107.03 - 198.77 | ||
| Bearish Scenario | 148.45 | 146.97 | 132.27 - 161.66 |
| 145.48 | 116.38 - 174.58 | ||
| 144.00 | 100.80 - 187.20 |
Overview of Nath Bio-Genes (India) Limited
ISIN
INE448G01010
Industry
Agricultural Inputs
Vol.Avg
17,794
Market Cap
2,842,808,360
Last Dividend
2
Official Website
IPO Date
2014-01-28
DCF Diff
-210.60
DCF
360
Financial Ratios Every Investor Needs
Stock Dividend of NATHBIOGEN
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-08-14 | August 14, 25 | 2 | 2 | 2025-08-14 | 2025-09-21 | |
| 2024-08-09 | August 09, 24 | 2 | 2 | 2024-08-09 | 2024-09-16 | |
| 2023-07-04 | July 04, 23 | 2 | 2 | 2023-07-04 | 2023-08-10 | |
| 2021-08-18 | August 18, 21 | 2 | 2 | 2021-08-21 | 2021-09-26 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 364.91 Cr | 135.55 Cr | 229.36 Cr | 0.6285 | 0.00 Cr | 32.50 Cr | 45.98 Cr | 38.60 Cr | 20.31 | 49.80 Cr | 0.1058 |
| 2024-03-31 | 247.53 Cr | 144.41 Cr | 103.11 Cr | 0.4166 | 11.28 Cr | 7.29 Cr | 47.70 Cr | 39.62 Cr | 20.85 | 53.64 Cr | 0.1601 |
| 2023-03-31 | 301.29 Cr | 134.59 Cr | 166.70 Cr | 0.5533 | 9.37 Cr | 5.68 Cr | 173.31 Cr | 35.01 Cr | 18.42 | 48.89 Cr | 0.1162 |
| 2022-03-31 | 278.36 Cr | 123.97 Cr | 154.39 Cr | 0.5546 | 8.89 Cr | 6.60 Cr | 137.60 Cr | -67.34 Cr | -35.43 | -49.71 Cr | -0.2419 |
| 2021-03-31 | 307.34 Cr | 136.09 Cr | 171.25 Cr | 0.5572 | 9.15 Cr | 5.09 Cr | 65.23 Cr | 55.66 Cr | 29.29 | 68.43 Cr | 0.1811 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 88.90 Cr | 1,026.21 Cr | 381.82 Cr | 644.3871 Cr | 122.50 Cr | 33.60 Cr | 338.02 Cr | 243.19 Cr | 0.00 Cr | 0.00 Cr | 5.78 Cr | 365.3008 Cr |
| 2024-03-31 | 77.40 Cr | 880.23 Cr | 270.31 Cr | 609.9187 Cr | 110.35 Cr | 32.94 Cr | 230.31 Cr | 281.52 Cr | 64.60 Cr | 0.00 Cr | 16.95 Cr | 262.4470 Cr |
| 2023-03-31 | 38.00 Cr | 792.80 Cr | 219.62 Cr | 573.1733 Cr | 105.21 Cr | 67.22 Cr | 207.85 Cr | 233.96 Cr | 0.87 Cr | 0.00 Cr | 5.05 Cr | 216.4534 Cr |
| 2022-03-31 | 4.17 Cr | 741.91 Cr | 199.94 Cr | 541.9695 Cr | 92.96 Cr | 88.79 Cr | 220.34 Cr | 232.85 Cr | 23.84 Cr | 0.00 Cr | 5.05 Cr | 194.2909 Cr |
| 2021-03-31 | 29.21 Cr | 789.51 Cr | 176.23 Cr | 613.2788 Cr | 96.57 Cr | 67.36 Cr | 226.30 Cr | 233.30 Cr | 2.53 Cr | 0.00 Cr | 5.05 Cr | 173.0038 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 17.5814 Cr | -3.9620 Cr | -2.1301 Cr | 9.6610 Cr | 11.4893 Cr | 88.8992 Cr | -7.9204 Cr | 38.5998 Cr | 12.1545 Cr | -3.8008 Cr | -107.7068 Cr |
| 2024-03-31 | 74.5937 Cr | -27.4011 Cr | -7.7780 Cr | 47.8181 Cr | 39.4147 Cr | 77.4099 Cr | -26.7756 Cr | 41.5647 Cr | 5.1341 Cr | -3.8008 Cr | -22.4625 Cr |
| 2023-03-31 | 38.3668 Cr | -2.8840 Cr | -1.6682 Cr | 35.8180 Cr | 33.8146 Cr | 37.9952 Cr | -2.5488 Cr | 36.1643 Cr | 12.2537 Cr | -3.8008 Cr | 12.4962 Cr |
| 2022-03-31 | 17.0463 Cr | -19.8664 Cr | -22.2266 Cr | -3.9703 Cr | -25.0481 Cr | 4.1680 Cr | -21.0166 Cr | -63.3865 Cr | -7.8202 Cr | -3.8008 Cr | 5.9571 Cr |
| 2021-03-31 | 1.1129 Cr | -10.2822 Cr | 16.4007 Cr | -10.4856 Cr | 7.2313 Cr | 29.2161 Cr | -11.5984 Cr | 56.7511 Cr | 25.2201 Cr | 0.0000 Cr | -21.9918 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 65.96 Cr | 41.36 Cr | 24.60 Cr | 0.3730 | 2.60 Cr | 1.60 Cr | 0.84 | 8.00 Cr | 0.0243 |
| 2025-09-30 | 43.85 Cr | 28.48 Cr | 15.37 Cr | 0.3505 | 5.12 Cr | 4.82 Cr | 1.40 | 10.10 Cr | 0.1098 |
| 2025-06-30 | 283.70 Cr | 139.82 Cr | 143.88 Cr | 0.5071 | 37.31 Cr | 37.28 Cr | 18.50 | 40.05 Cr | 0.1314 |
| 2025-03-31 | 51.97 Cr | 17.68 Cr | 34.29 Cr | 0.6598 | -0.93 Cr | 1.48 Cr | 0.45 | 4.28 Cr | 0.0285 |
| 2024-12-31 | 36.87 Cr | 12.49 Cr | 24.39 Cr | 0.6613 | 7.21 Cr | 2.65 Cr | 1.33 | 8.51 Cr | 0.0719 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 0.74 Cr | 158.13 Cr | 158.87 Cr | 228.88 Cr | 307.96 Cr | 706.39 Cr | 243.08 Cr | 1,014.18 Cr | 334.32 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 88.90 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -644.39 Cr |
| 2025-03-31 | 88.90 Cr | 0.00 Cr | 88.90 Cr | 88.90 Cr | 338.02 Cr | 690.01 Cr | 243.19 Cr | 1,026.21 Cr | 381.82 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 2.08 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -640.27 Cr |
| 2024-09-30 | 2.08 Cr | 0.00 Cr | 2.08 Cr | 147.71 Cr | 167.14 Cr | 515.62 Cr | 243.04 Cr | 828.48 Cr | 188.21 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 37.28 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 1.48 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 2.65 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 1.11 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 33.35 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Agricultural Inputs
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Coromandel International Limited | COROMANDEL | ₹2,073.10 | ₹610,980,588,581.00 | ₹1,278,017.00 |
| UPL Limited | UPL | ₹630.30 | ₹532,077,199,500.00 | ₹1,476,737.00 |
| The Fertilisers And Chemicals Travancore Limited | FACT | ₹794.50 | ₹514,098,683,343.00 | ₹8,171,463.00 |
| PI Industries Limited | PIIND | ₹3,083.60 | ₹467,792,076,944.00 | ₹140,106.00 |
| Bayer CropScience Limited | BAYERCROP | ₹4,604.30 | ₹206,926,874,196.00 | ₹15,166.00 |
| Sumitomo Chemical India Limited | SUMICHEM | ₹393.65 | ₹196,488,718,976.00 | ₹304,341.00 |
| Chambal Fertilisers and Chemicals Limited | CHAMBLFERT | ₹431.55 | ₹172,901,498,770.00 | ₹2,261,647.00 |
| Sharda Cropchem Limited | SHARDACROP | ₹1,030.00 | ₹92,927,109,850.00 | ₹240,935.00 |
| Paradeep Phosphates Limited | PARADEEP | ₹108.11 | ₹88,288,196,260.00 | ₹10,555,434.00 |
| Rashtriya Chemicals and Fertilizers Limited | RCF | ₹127.68 | ₹70,439,536,608.00 | ₹68,566,776.00 |
| Gujarat State Fertilizers & Chemicals Limited | GSFC | ₹162.98 | ₹64,943,867,839.00 | ₹6,345,104.00 |
| Rallis India Limited | RALLIS | ₹253.45 | ₹49,288,140,171.00 | ₹311,968.00 |
| Dhanuka Agritech Limited | DHANUKA | ₹992.40 | ₹44,735,728,738.00 | ₹21,186.00 |
| Madhya Bharat Agro Products Limited | MBAPL | ₹463.25 | ₹40,593,179,955.00 | ₹220,670.00 |
| National Fertilizers Limited | NFL | ₹79.09 | ₹38,799,845,656.00 | ₹40,626,829.00 |
| Mangalore Chemicals & Fertilizers Limited | MANGCHEFER | ₹308.75 | ₹36,591,552,563.00 | ₹470,852.00 |
| Krishana Phoschem Limited | KRISHANA | ₹499.30 | ₹30,870,520,680.00 | ₹124,946.00 |
| Bhagiradha Chemicals & Industries Limited | BHAGCHEM | ₹199.18 | ₹25,827,487,354.00 | ₹129,737.00 |
Key Executives
Gender: Not Specified
Year Born: 1966
Gender: male
Year Born: 1961
Gender: Not Specified
Year Born: 1970
Gender: male
Year Born: 1961
Gender: male
Year Born:
Gender: male
Year Born: 1994
Gender: male
Year Born: 1974
Gender: male
Year Born: 1966
Gender: female
Year Born: 1948
Gender: male
Year Born: 1957
FAQs about Nath Bio-Genes (India) Limited
The CEO is Satish Kagliwal.
The current price is ₹149.59.
The range is ₹136-238.69.
The market capitalization is ₹284.28 crores.
The dividend yield is 1.34%.
The P/E ratio is 6.29.
The company operates in the Basic Materials sector.
Overview of Nath Bio-Genes (India) Limited (ISIN: INE448G01010) is a leading Agricultural Inputs in India. With a market capitalization of ₹284.28 crores and an average daily volume of 17,794 shares, it operates in the Agricultural Inputs. The company last declared a dividend of ₹2.